FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306406951> ?p ?o ?g. }

• W4306406951 endingPage "199" @default.
• W4306406951 startingPage "185" @default.
• W4306406951 abstract "The relationship between metabolism and immune microenvironment remains to be studied in bladder cancer (BCa). We aimed to construct a metabolic-associated signature for prognostic prediction and investigate its relationship with the immune microenvironment in BCa. The RNA expression of metabolism associated genes was obtained from a combined data set including The Cancer Genome Atlas, GSE48075, and GSE13507 to divide BCa patients into different clusters. A metabolic-associated signature was constructed using the differentially expressed genes between clusters in the combined data set and validated in the IMvigor210 trial and our center. The composition of tumor-infiltrating immune cells (TIICs) was evaluated using the single-sample Gene Set Variation Analysis. BCa patients in Cluster A or high-risk level were associated with advanced clinicopathological features and poor survival outcomes. The percentage of high-risk patients was significantly lower in patients responding to anti-PD-L1 treatment. Compared with low-risk patients, the IC50 values of cisplatin and gemcitabine were significantly lower in high-risk patients. Thiosulfate transferase (TST) and S100A16 were significantly associated with clinicopathological features and prognosis. Downregulation of TST promoted BCa cell invasion, migration, and epithelial-to-mesenchymal transition, which are inhibited by downregulation of S100A16. CD8 + T cells, neutrophils, and dendritic cells had higher infiltration in the TST low-level and the S100A16 high-level. Furthermore, loss of function TST and S100A16 significantly affected the expression of PD-L1 and CD47. The metabolic-associated signature can stratify BCa patients into distinct risk levels with different immunotherapeutic susceptibility and survival outcomes. Metabolism disorder promoted the dysregulation of immune microenvironment, thus contributing to immunosuppression." @default.
• W4306406951 created "2022-10-17" @default.
• W4306406951 creator A5006457719 @default.
• W4306406951 creator A5006610135 @default.
• W4306406951 creator A5007580964 @default.
• W4306406951 creator A5009907279 @default.
• W4306406951 creator A5012184118 @default.
• W4306406951 creator A5017842955 @default.
• W4306406951 creator A5022598327 @default.
• W4306406951 creator A5026418345 @default.
• W4306406951 creator A5033020983 @default.
• W4306406951 creator A5049225160 @default.
• W4306406951 creator A5068062810 @default.
• W4306406951 creator A5089732894 @default.
• W4306406951 date "2022-10-17" @default.
• W4306406951 modified "2023-10-16" @default.
• W4306406951 title "Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer" @default.
• W4306406951 cites W1131085297 @default.
• W4306406951 cites W1851468002 @default.
• W4306406951 cites W1973260880 @default.
• W4306406951 cites W2005334224 @default.
• W4306406951 cites W2058648826 @default.
• W4306406951 cites W2059758368 @default.
• W4306406951 cites W2090268153 @default.
• W4306406951 cites W2108929503 @default.
• W4306406951 cites W2127463721 @default.
• W4306406951 cites W2135272175 @default.
• W4306406951 cites W2141643459 @default.
• W4306406951 cites W2152455106 @default.
• W4306406951 cites W2157739158 @default.
• W4306406951 cites W2268142169 @default.
• W4306406951 cites W2295358293 @default.
• W4306406951 cites W2295699452 @default.
• W4306406951 cites W2622008929 @default.
• W4306406951 cites W2737046088 @default.
• W4306406951 cites W2765685996 @default.
• W4306406951 cites W2765965148 @default.
• W4306406951 cites W2773997843 @default.
• W4306406951 cites W2892569486 @default.
• W4306406951 cites W2895985564 @default.
• W4306406951 cites W2922818012 @default.
• W4306406951 cites W2942396571 @default.
• W4306406951 cites W2965716756 @default.
• W4306406951 cites W2969983122 @default.
• W4306406951 cites W2992497359 @default.
• W4306406951 cites W2999417355 @default.
• W4306406951 cites W2999659032 @default.
• W4306406951 cites W2999754525 @default.
• W4306406951 cites W3006073202 @default.
• W4306406951 cites W3015450697 @default.
• W4306406951 cites W3023288864 @default.
• W4306406951 cites W3040651070 @default.
• W4306406951 cites W3118099026 @default.
• W4306406951 cites W3118397842 @default.
• W4306406951 cites W3136052808 @default.
• W4306406951 cites W3138368570 @default.
• W4306406951 cites W3161452684 @default.
• W4306406951 cites W3215323199 @default.
• W4306406951 cites W4211053712 @default.
• W4306406951 doi "https://doi.org/10.1002/mc.23475" @default.
• W4306406951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36250643" @default.
• W4306406951 hasPublicationYear "2022" @default.
• W4306406951 type Work @default.
• W4306406951 citedByCount "2" @default.
• W4306406951 countsByYear W43064069512023 @default.
• W4306406951 crossrefType "journal-article" @default.
• W4306406951 hasAuthorship W4306406951A5006457719 @default.
• W4306406951 hasAuthorship W4306406951A5006610135 @default.
• W4306406951 hasAuthorship W4306406951A5007580964 @default.
• W4306406951 hasAuthorship W4306406951A5009907279 @default.
• W4306406951 hasAuthorship W4306406951A5012184118 @default.
• W4306406951 hasAuthorship W4306406951A5017842955 @default.
• W4306406951 hasAuthorship W4306406951A5022598327 @default.
• W4306406951 hasAuthorship W4306406951A5026418345 @default.
• W4306406951 hasAuthorship W4306406951A5033020983 @default.
• W4306406951 hasAuthorship W4306406951A5049225160 @default.
• W4306406951 hasAuthorship W4306406951A5068062810 @default.
• W4306406951 hasAuthorship W4306406951A5089732894 @default.
• W4306406951 hasBestOaLocation W43064069512 @default.
• W4306406951 hasConcept C104317684 @default.
• W4306406951 hasConcept C121608353 @default.
• W4306406951 hasConcept C126322002 @default.
• W4306406951 hasConcept C127561419 @default.
• W4306406951 hasConcept C143998085 @default.
• W4306406951 hasConcept C150194340 @default.
• W4306406951 hasConcept C203014093 @default.
• W4306406951 hasConcept C2776107976 @default.
• W4306406951 hasConcept C2779733811 @default.
• W4306406951 hasConcept C2780352672 @default.
• W4306406951 hasConcept C502942594 @default.
• W4306406951 hasConcept C54355233 @default.
• W4306406951 hasConcept C71924100 @default.
• W4306406951 hasConcept C86803240 @default.
• W4306406951 hasConcept C8891405 @default.
• W4306406951 hasConceptScore W4306406951C104317684 @default.
• W4306406951 hasConceptScore W4306406951C121608353 @default.
• W4306406951 hasConceptScore W4306406951C126322002 @default.
• W4306406951 hasConceptScore W4306406951C127561419 @default.

• next